The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease
Authors:
- 17 February 2009
- journal article
- clinical trial
- Published by Wiley in Movement Disorders
- Vol. 24 (5) , 762-766
Abstract
“Pulsatile” administration of levodopa has been invocated a relevant factor for motor fluctuations in Parkinson's disease (PD). We studied dopaminergic sensitivity to apomorphine in 10 parkinsonian patients with motor fluctuations. Patients were tested as follows: the minimal effective dose of apomorphine (MED‐1) was administered in the morning to induce anonresponse. Fifteen minutes after this motor response had disappeared, an apomorphine infusion was initiated and maintained to ensureonperiods of three different durations on different days. Infusion lasted for ∼30, 60 and 90 minutes. Subsequently, the infusion was stopped, and after 15 minutes in theoffstate, a second bolus of apomorphine (MED‐2) was given. The mean infusion doses were 49.2 ± 5.4, 108.4 ± 10.3, and 150 ± 8.2 mg. These elicitedonperiods of 48.2 ± 4.1, 110 ± 4.5, and 195 ± 3.8 minutes. The MED‐2 elicitedonresponses with a duration of 30 ± 4.5, 18.4 ± 3.2, and 11.2 ± 4.1 minutes. The duration of theonresponse induced by the apomorphine infusions correlated inversely (P< 0.01) with theoninduced by the MED‐2 of apomorphine. Our findings indicate that a continuous dopaminergic stimulus may induce pharmacodynamic changes associated with tolerance in PD patients. © 2009 Movement Disorder SocietyKeywords
This publication has 33 references indexed in Scilit:
- Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primatesExperimental Neurology, 2005
- The neurochemistry of therapeutics: Levodopa pharmacodynamics in Parkinson's diseaseAnnals of Neurology, 2001
- Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease: PET evidence of increased dopamine turnoverAnnals of Neurology, 2001
- Apomorphine induces changes in GPi spontaneous outflow in patients with parkinson's diseaseMovement Disorders, 1999
- Levodopa Consumption Reduces Dopaminergic Receptor Responsiveness in Parkinsonʼs DiseaseClinical Neuropharmacology, 1989
- Continuous and intermittent levodopa differentially affect basal ganglia functionAnnals of Neurology, 1989
- Motor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, Part IAnnals of Neurology, 1988
- Central Mechanisms and Levodopa Response Fluctuations in Parkinsonʼs DiseaseClinical Neuropharmacology, 1988
- Long‐term duodenal infusion of levodopa for motor fluctuations in parkinsonismAnnals of Neurology, 1988
- Dopamine D2 receptor density remains constant in treated Parkinson's diseaseAnnals of Neurology, 1986